Clinical Trial: Clinical Benefit of 18F-FET in Glioma.

U.S., July 14 -- ClinicalTrials.gov registry received information related to the study (NCT07698457) titled 'Clinical Benefit of 18F-FET in Glioma.' on July 01.

Brief Summary: This Phase II clinical trial, sponsored by **Primo Biotechnology Co., Ltd.**, evaluates the clinical benefit of **$^{18}$F-FET PET/CT** in diagnosing glioma. The study aims to compare the diagnostic performance of $^{18}$F-FET PET imaging against traditional brain MRI, using surgical histopathology as the gold standard for verification.

**Study Design and Participants** This is a single-center, open-label, non-randomized trial conducted in Taiwan. The study will enroll a total of **36 participants**, consisting of 6 healthy volunteers (to assess biodistribution and ...